The Lancet Diabetes & Endocrinology2019Open AccessHighly Cited

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund et al.

1,558 citations2019Open Access — see publisher for license terms1 related compound

Research Article — Peer-Reviewed Source

Original research published by Kristensen et al. in The Lancet Diabetes & Endocrinology. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.

Full Text

Full text is available at the publisher.

Read at Publisher
Article Details
DOI10.1016/s2213-8587(19)30249-9
JournalThe Lancet Diabetes & Endocrinology
Year2019
AuthorsSøren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, Kieran F. Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C. Petrie, John J.V. McMurray
LicenseOpen Access — see publisher for license terms
Citations1,558